Point of Care

NABAS develops cutting edge species specific Point-of-care immunoassays, for the use in human and veterinarian diagnostics, using more than 20 years of experience in the production of chicken antibodies and more than 40 years of experience with the development of diagnostic tests. These Point of Care immunoassys allows the study of biological systems by tracking different proteins and hormones and improves diagnostics both in regards to welfare and quicker treatment.
NABAS has now developed a new and improved vertical flow immunoassays that allows for the use of small whole canine blood samples to be tested for the analyse canine C-reactive Protein using colored immuneparticles. This test will be launched in Q3 2018. 
Immunoassays have been used for several decades, and are today important tools in both human and veterinary medicine and research. Information gained by clinical immunoassay testing has shortened hospital stays and decreased the severity of illness by assisting medical staff in rapidly identifying and assessing the progression of disease, thereby leading to improved therapeutic choices. Please contact us for more information. 
Skriv ut